165530_bioimage

Lori B. Green



Lori Green is an experienced transactional business lawyer with almost 30 years of domestic and international experience in a wide range of business law matters. She has been the responsible partner for numerous transactions, including public and privately negotiated acquisitions, divestitures, joint ventures, cross-border transactions, outsourcing transactions, restructurings and financings. Such transactions have involved representing companies in a variety of regulated and unregulated industries, with a particular focus on energy, life sciences, health care, manufacturing and technology.

Lori has held numerous leadership positions at Nixon Peabody, including three years of service as the chairperson of the firm’s Policy Committee, an elected oversight and policy-making body for the firm, and currently serves as co-leader of the firm’s M&A and Corporate Transactions team.

What do you focus on?

Energy

In the transmission area I served as project counsel to the 11 load-serving entities that are participants in the more than $2.0 Billion CapX 2020 Transmission Expansion Projects. I led the negotiation among the participants of key project agreements including the project participation agreement. My partner Bill Andrews and I were selected by The American Lawyer as one of its “Dealmakers of the Year 2011” for our work on the CapX 2020 Projects. In the generation area, I served as counsel to the Indiana Municipal Power Agency, which led the team negotiating project agreements including the participation agreement, project development agreement and asset purchase agreement among six public power participants and Peabody Energy in connection with the development of Prairie State, a 1600 MW, mine-mouth, pulverized coal-fired power plant now in service in southern Illinois. These are two examples of the many entities I have represented in developing, acquiring or disposing of transmission and generation assets.

Life Sciences

I have been responsible for leading numerous transactions for Bausch & Lomb Incorporated, including the acquisition of eyeonics, Inc., and worldwide rights for certain pharmaceutical products. I have also counseled life sciences entities in connection with commercial arrangements, including licensing, co-development and co-promotion agreements.

Health Care

I have represented hospitals, ambulatory surgery centers, laboratories, medical and dental practice management companies and medical and dental practices and providers in connection with acquisitions, dispositions, joint ventures, roll-ups, commercial arrangements, etc. A few health care companies I currently represent include NAPA Management Services Corporation, North American Partners In Anesthesia, LLP, Excelsior Orthopaedics, LLP and Buffalo Surgery Center, LLC.

Manufacturing and Technology

I was responsible for leading the project team representing Xerox Corporation in connection with its $5 billion equipment financing agreement with GE Capital Corporation and its administrative services joint venture agreement with GE Capital. I have led transactions of all sorts for companies in this space and across the growth spectrum, ranging from large public companies such as Harsco Corporation to smaller private companies such as Ameritherm, Inc., to startup companies.

What do you see on the horizon?

In the energy area, I think we will increasingly see multi-party transactions enabling businesses with common objectives to develop large-scale energy assets on a jointly owned basis. Multi-party transactions allow each participant to calibrate the size of its investment with its appetite for development and operating risk and its appetite for control. From a project perspective, our experience shows that assembling the vast amounts of capital that large energy infrastructure requires is more easily accomplished in a tenant-in-common structure in a manner that is consistent with each participant’s financing abilities and without the complications of inter-creditor arrangements.

I see the life sciences and health care areas converging with more collaboration among biopharma companies, health systems, providers and patients. The pace of this convergence will accelerate with continued major developments in medical science and information technology.

Publications

Advice from corporate attorneys: Listen and learn

Rochester Business Journal | December 04, 2018

Rochester Corporate partners Lori Green and Tyler Savage are quoted in this article on the insights they’ve gathered throughout years of practice, and what advice they’d give to up-and-coming attorneys.

Constellation Brands/Canopy Growth Corp.

The American Lawyer | December 01, 2018

Nixon Peabody is mentioned as U.S. counsel for longtime client Constellation Brands in its acquisition of a 38 percent stake in Canopy Growth Corp., a Canadian distributor of cannabis products. The following attorneys were members of the deal team: Rochester Corporate partner Lori Green, Boston Global Finance partner Craig Mills, Washington, D.C. Corporate partner Lloyd Spencer, San Francisco Global Finance counsel Sarah Abel, Buffalo Global Finance associate Dan Fabian, Rochester Corporate associate Isaac Figueras, and Washington, D.C. Corporate associate Pierce Han.

$4.8B Akorn ruling more outlier than shift at Chancery

Law360 | October 15, 2018

In the following coverage, Rochester Corporate partner Lori Green, Complex Commercial Disputes partners Rick McGuirk and Carolyn Nussbaum, and New York City Complex Commercial Disputes partner Chris Mason analyze a key ruling by the Delaware Chancery Court that affirmed the existence of a material adverse event allowing German pharmaceutical company Fresenius to back down from a merger with Akorn, Inc.

Delaware Chancery Court issues rare decision finding Material Adverse Effect justifying termination of merger

Law360 | October 15, 2018

In the following coverage, Rochester Corporate partner Lori Green, Complex Commercial Disputes partners Rick McGuirk and Carolyn Nussbaum, and New York City Complex Commercial Disputes partner Chris Mason analyze a key ruling by the Delaware Chancery Court that affirmed the existence of a material adverse event allowing German pharmaceutical company Fresenius to back down from a merger with Akorn, Inc.

Constellation stashes more Canopy Growth

The Deal | August 15, 2018

Seven attorneys from the Corporate and Global Finance practices—Lori Green, Sarah Abel, Dan Fabian, Isaac Figueras, Pierce Han, Craig Mills and Lloyd Spencer—are mentioned in this story for advising client Constellation Brands on its cash investment in Canopy Growth Corp.

Contact

Lori B. Green

Partner
Co-Leader, M&A and Corporate Transactions Team

Rochester

Phone: 585-263-1236


Mobile: 585-281-3076

Fax: 866-947-1133

Boston University School of Law, J.D.

State University of New York at Binghamton, B.A., Mathematics

Harvard Business School, Executive Program

New York

Florida

Lori was selected by her peers for inclusion in The Best Lawyers in America© 2019 in the fields of Corporate Law and Mergers and Acquisitions Law. Lori has been listed in Best Lawyers since 2012, and was named 2019 Mergers and Acquisitions Law "Lawyer of the Year" and 2017 Corporate Law “Lawyer of the Year” in Rochester, NY.

Lori has been recognized for exceptional standing in the legal community in Chambers USA: America’s Leading Lawyers for Business 2018 for Corporate/M&A (New York (Upstate)). She has also been recognized in Chambers in previous years.

Lori was selected to the Upstate New York Super Lawyers list in 2012-2015. Her primary area of practice is mergers & acquisitions law.

Lori presently serves as the Vice-Chair and Secretary of the Board of Directors of High Technology of Rochester, Inc., the Secretary of the Board of Director of Greater Rochester Enterprise, and is on several committees of the United Way of Greater Rochester. She is a member of the American, New York State and Monroe County Bar Associations.

Back to top